Health Care • Medical/Nursing Services
$15.50 ▲ +0.20
(+1.31%)
MKT CAP: $46.4M • VOL: 45.0K
52W L $5 52W H $71
ROARABLE / RQD
D- • 39/100
PIOTROSKI
4 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$13
MEDIAN
$17
MEAN
$18
HIGH
$21
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE EUDA TAPE
EUDA // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $18.75 | $17.82 | 2025-02-14 | $14.11 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $19.53 | $18.29 | 2025-02-06 | $14.57 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $17.67 | $17.05 | 2025-01-29 | $14.88 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $15.81 | — | 2025-01-17 | $15.19 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $13.64 | $14.72 | 2025-01-09 | $13.79 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $18.45 | $16.12 | 2024-12-18 | $13.48 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $15.04 | $15.65 | 2024-12-04 | $14.42 | -4.3% | 48% | C |